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genes and neurotrophic factor systems implicated in the 
pathophysiology of depression. Differential expression of 
the clock gene Bhlhe40 and the neurotrophic factor Vegfb 
were found in the beginning of the active (dark) phase in 
Cry2−/− compared to wild-type animals. Furthermore, 
amygdala tissue of Cry2−/− mice contained lower levels 
of Bdnf-III. Collectively, these results indicate that Cry2 
exerts a critical role in the control of depression-related 
emotional states and modulates the chronobiological gene 
expression profile in the mouse amygdala.
Keywords Cry2 · Amygdala · Depression · Anhedonia · 
Clock gene · VEGF
Introduction
Cryptochrome 2 (Cry2) is one of the key components of 
the mammalian intrinsic clock (Griffin et al. 1999; van 
der Horst et al. 1999; Vitaterna et al. 1999). The genetic 
core of circadian clocks is constituted of about 20 clock 
genes, whose expression is regulated by transcriptional 
and translational feedback loops (Albrecht 2012). In this 
system, Cry2, together with the clock proteins Cry1, Per1 
and Per2, forms a heterodimeric repressor complex which 
attenuates the Clock/Npas2-Arntl(Bmal1)/Arntl2(Bmal2) 
activator complex (Gekakis et al. 1998; Kume et al. 1999). 
In contrast to most core elements of the molecular time 
keeping system (including Clock, Npas2, Arntl, Arntl2 and 
the Per proteins), the cryproteins have no Per-ARNT-Sim 
(PAS) domain (Hsu et al. 1996). However, they have been 
identified to be required for the maintenance of circadian 
rhythms. Albeit the fact that absence of either gene alone 
modulates the period length of the free-running circadian 
rhythm in opposing directions, the concomitant deletion 
Abstract Mood disorders are frequently paralleled by 
disturbances in circadian rhythm-related physiological and 
behavioral states and genetic variants of clock genes have 
been associated with depression. Cryptochrome 2 (Cry2) 
is one of the core components of the molecular circadian 
machinery which has been linked to depression, both, in 
patients suffering from the disease and animal models of 
the disorder. Despite this circumstantial evidence, a direct 
causal relationship between Cry2 expression and depres-
sion has not been established. Here, a genetic mouse model 
of Cry2 deficiency (Cry2−/− mice) was employed to test 
the direct relevance of Cry2 for depression-like behavior. 
Augmented anhedonic behavior in the sucrose preference 
test, without alterations in behavioral despair, was observed 
in Cry2−/− mice. The novelty suppressed feeding paradigm 
revealed reduced hyponeophagia in Cry2−/− mice com-
pared to wild-type littermates. Given the importance of the 
amygdala in the regulation of emotion and their relevance 
for the pathophysiology of depression, potential alterations 
in diurnal patterns of basolateral amygdala gene expression 
in Cry2−/− mice were investigated focusing on core clock 
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of both proteins results in a total abolition of free-running 
rhythmicity (van der Horst et al. 1999).
Disturbances in circadian rhythm-related physiological 
and behavioral states are frequently observed in mood dis-
orders (Carpenter and Bunney 1971; Branchey et al. 1982; 
von Zerssen et al. 1987; Souetre et al. 1988, 1989; Benca 
et al. 1992). Interestingly, although the suprachiasmatic 
nucleus (SCN) of the hypothalamus constitutes the master 
organizer of the body’s molecular circadian rhythm, clock 
genes are also expressed in other regions of the brain, 
including those relevant to the pathophysiology of depres-
sion, such as the amygdala and the hippocampus (Lamont 
et al. 2005; Jilg et al. 2010; Li et al. 2013; Savalli et al. 
2014). Cry2 is highly expressed in the SCN, albeit infor-
mation on its rhythmic oscillation is controversial (Kume 
et al. 1999; Mendoza et al. 2005). A diurnal pattern of its 
expression has been also observed in the amygdala, where 
it may additionally exert non-circadian functions. Indeed, 
the observed rhythmic oscillation of Cry2 in the amygdala 
is disrupted in an animal model of a mood disorder charac-
terized by increased anhedonic behavior following chronic 
mild stress (Savalli et al. 2014). Furthermore, mice dis-
playing higher trait-anxiety behavior (HAB) and comor-
bid depression-like behavior (Sah et al. 2012) also express 
lower levels of Cry2 in the hippocampus as compared to 
normal anxiety/depression-like behavior (NAB) mice 
(Griesauer et al. 2014). These observations suggest that 
altered circadian rhythms and depression-related behavior 
may be linked at the genetic level. Specifically, they point 
towards a key role for Cry2, supported by genetic studies 
in the human population highlighting the association of 
Cry2 with mood disorders and their depressive episodes 
(Lavebratt et al. 2010; Sjoholm et al. 2010; Kovanen et al. 
2013).
Despite this circumstantial evidence for a role of Cry2 
in the pathophysiology of mood disorders, a causal link 
between altered Cry2 expression and depression-like 
behavior has not been established so far. The present 
study aimed at investigating the direct consequences of 
Cry2-deficiency on depression-like behavior in the mouse 
and to determine its molecular signature in the baso-
lateral amygdala. Specifically, we investigated whether 
the lack of Cry2 causes changes diurnal pattern in clock 
gene expression in amygdala. Additionally, given the 
critical importance of growth factor support and defi-
ciencies thereof in the pathophysiology of depression, 
we further aimed to investigate whether Cry2-deficiency 
affects expression of the vascular endothelial growth fac-
tor (VEGF) and of the brain derived neurotrophic factor 
(BDNF), which have been both associated to depressive 
disorders (as reviewed in Yu and Chen 2011; Clark-Ray-
mond and Halaris 2013).
Materials and methods
Male adult Cry2 knock-out (Cry2−/−) and wild-type lit-
termates (Cry2+/+) maintained at a C57BL/6J-background 
(B6.129P2-Cry2tm1Asn/J) were used (Jackson Laboratory, 
MA, USA). This strain was created by replacement of the 
flavine adenine dinucleotide (FAD) binding domain by a 
neomycin resistance cassette (Thresher et al. 1998; http://
jaxmice.jax.org/). Mice were 9–10 weeks old at the onset 
of experiments. Animals were single-housed in a sound-
attenuated room with constant temperature of ≈21 °C 
under a 12:12-h light/dark cycle (lights on at 6:00 a.m.). 
The light intensity at the level of the animal cages was 
≈200 lux. Food and water were freely available through-
out the experiment, unless otherwise specified. All experi-
ments were designed to reduce animal suffering and keep 
the number of animals used at the minimum level. Ani-
mal experiments described in this study were approved 
by the national ethical committee on animal care and use 
(BMWF-66.009/0302-II/3b/2013; Bundesministerium für 
Wissenschaft und Forschung) and carried out according to 
international laws and policies.
Behavioral experiments
All behavioral tests were performed during the light cycle. 
Mice were habituated to the experimental room 30 min 
before each test. The same cohort of animals (wild-type, 
Cry2+/+ n = 12; Cry2−/− n = 12) was used in all tests. The 
order in which tests were performed followed recommen-
dations ranking the tests from least to more stressful (McIl-
wain et al. 2001) as follows: sucrose preference test, open 
field, Rota Rod, light/dark box, elevated plus maze, forced 
swim, tail suspension, novelty-suppressed feeding test. 
Prior to the initiation of behavioral testing, a gross evalua-
tion of basic neurological function was carried out follow-
ing an established protocol (Irwin 1968). In agreement with 
an earlier report (Thresher et al. 1998), no detectable dif-
ferences in basic neurological performance were observed 
between Cry2+/+ and Cry2−/− mice. A break of at least 
24 h was applied between individual tests. All experiments 
were made by an investigator blind to the genotype of each 
animal.
Sucrose preference test (SPT)
The SPT was carried out essentially as previously described 
(Khan et al. 2014). Briefly, prior to testing, mice were 
habituated to drink a 2 %-sucrose solution, during 4 days 
of training. On day 1 of the training, mice were deprived of 
food and water for 18 h. On day 2 and 3, mice were given 
a 2 %-sucrose solution and food was restored. On day 4, 
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the sucrose solution was replaced with tap water for 6 h. 
Animals were then deprived of food and water and tested 
for sucrose preference 18 h later. During the test, subjects 
were given a free choice between two bottles, one with 
the sucrose solution and the other with water. Mice were 
tested over 3 h, starting at 9:00 a.m. To prevent possible 
effects of side preference in drinking behavior, the posi-
tion of the bottles (right or left of the feeding compartment) 
was alternated between animals. Total liquid consumption 
was measured by weighing the bottles before and after the 
SPT. Sucrose preference was calculated according to the 
formula: percentage of preference = (sucrose intake/total 
intake) × 100.
Novelty‑suppressed feeding test (NSF)
The NSF test measures the latency(s) of the subject to 
the first feeding event in a novel environment. It was per-
formed essentially as described by Mineur et al. (2007) 
with minor modifications. The testing apparatus consisted 
of a clear Plexiglas arena (33 × 47 × 17 cm), brightly lit 
(800 lux). At the beginning of the experiment, each subject 
was placed in the corner of the novel arena with a food pel-
let positioned in the center and the latency to the first bite 
of food was recorded (maximum time 600 s). After the test 
food consumption in the home cage was evaluated during 
5 min.
Forced swim test (FST)
The FST was conducted as previously described (Monje 
et al. 2011a). Behavior patterns were tracked by VID-
EOTRACK (PORSOLT) software provided (Viewpoint, 
Champagne au mont d’Or, France) during a 6-min session. 
The last 4 min of the test were used to assess the percent-
age of time spent immobile.
Tail suspension test (TST)
The TST was conducted as previously described (Monje 
et al. 2011a), with minor modifications. Mice were securely 
fastened by the distal end of the tail to a metallic hook in 
a tail suspension system (MedAssociates, St Albans, VT, 
USA). The presence or absence of immobility, defined as 
the absence of limb movement, was tracked over a 6-min 
session by a computational tracking system (Activity Mon-
itor, MedAssociates, St Albans, VT, USA). Percentage of 
time spent immobile over the total time was assessed.
Open field (OF)
The OF followed a protocol previously described (Monje 
et al. 2011a). Briefly, locomotor activity was monitored 
by a computational tracking system (Activity Monitor, 
MedAssociates, St Albans, VT, USA). The total distance 
covered during the 30 min testing time and the time spent 
in the center zone were evaluated.
Rota Rod test
The Rota Rod test followed a published procedure (Khan 
et al. 2014). Each mouse was placed separately on one 
lane of the rotating drum of an automated Rota Rod device 
(USB Rota Rod ‘SOF-ENV-57X’, MedAssociates, St 
Albans, VT, USA). The latency to fall off the drum was cal-
culated as the mean value of three consecutive test sessions.
Elevated plus maze (EPM)
The EPM was conducted as previously described elsewhere 
(Shumyatsky et al. 2002). Briefly, the apparatus consisted 
of a center platform with adjacent two open and two closed 
arms. Subjects were placed in the center and their behavior 
was recorded for 5 min by a computational tracking system 
(Viewpoint, Champagne au mont d’Or, France). Percentage 
of time spent in open arms and percentage of number of 
open arm entries were assessed.
Light/dark box test (LD)
The LD followed a published protocol with minor modi-
fications (Leach et al. 2013). The testing apparatus con-
sisted of a dark and a lit compartment, connected by an 
opening between the two (MedAssociates, St Albans, VT, 
USA). Animals were allowed to freely move between the 
two compartments, and the percentage of time spent in and 
the number of entries into the lit compartment were meas-
ured by a computational tracking system (Activity Moni-
tor, MedAssociates, St Albans, VT, USA) during a 10-min 
session.
Tissue dissection
Mice of both genotypes were randomly divided into two 
groups and killed by neck dislocation at Zeitgeber Time 
(ZT) 0.5 (30 min after lights on), or ZT 12.5 (30 min 
after lights off). Brains were rapidly removed and imme-
diately frozen at −80 °C. Basolateral amygdala samples 
were collected using a micro-punch procedure (Lamprecht 
et al. 2002). Briefly, three adjacent brain coronal sections 
of 300 μm, from the rostral (Bregma −0.94 mm), medial 
(Bregma −1.24 mm) and caudal (Bregma −1.54 mm) 
amygdala (Paxinos and Franklin 2001) were collected. 
Three bilateral samples of basolateral amygdala were 
extracted with a blunted 0.69 mm inner diameter sam-
ple cannula (Fine Science Tools, Heidelberg, Germany), 
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put into 700 μl Qiazol lysis buffer, vortexed and kept at 
−80 °C until used for further analysis.
RNA isolation and quantitative real‑time PCR 
(qRT‑PCR)
Total RNA was isolated using a commercially available 
system [miRNA Micro Kit (Quiagen, CA, USA)], ampli-
fied using T-Script® reverse transcriptase (QuantiTect 
Whole Transcriptome, Quiagen, CA, USA) and quantified 
by the Quant-iT PicoGreen dsDNA Reagent (Invitrogen 
Corporation, Carlsbad, CA, USA). The reaction for the sub-
sequent qRT-PCR consisted of 2 μl cDNA sample (out of 
25 ng/μl dilution of amplified cDNA reaction) and 5.2 μl 
RNase-free water, together with 7.8 μl primer-specific 
master mix containing 7.5 μl Power SYBR® Green PCR 
Master Mix (Applied Biosystems, CA, USA), 0.15 μl for-
ward primer (20 μM) and 0.15 μl reverse primer (20 μM). 
The thermal cycling profiles were 50 °C for 2 min, 95 °C 
for 10 min, 40 cycles at 95 °C for 15 s and 60 °C or 62 °C 
for 1 min. Transcription levels of target genes were assayed 
in duplicates and normalized against the amount of β-actin 
mRNA [delta cycle threshold (dCT)]. β-actin was selected 
as reference gene as its expression was shown to be sta-
ble in mouse amygdala even after emotionally challeng-
ing conditions (Stork et al. 2001). Data were plotted using 
the formula: 2−∆dCT (ddCT), where ddCT is the difference 
between the mean dCT of each group and the mean dCT 
of the control group at ZT 0.5. Primers used for amplifica-
tion of Vegfa, Vegfb, Vegfc, Vegfd, Vegfr-1, Vegfr-2, Vegfr-3 
were described previously (Catteau et al. 2011). Primers 
used for amplification of Bdnf-I, Bdnf-II, Bdnf-III, Bdnf-IV, 
Bdnf-V, Bdnf (total) were described previously (Tsankova 
et al. 2006). Primer sequences for all clock genes analyzed 
[Clock, Bmal1, Cry1, Cry2, CycloB, Dbp, E4bp4, Id2, 
Npas2, Per1, Per2, Per3, Nr1d1 (Rev-erbα), Nr1d2 (Rev-
erbβ), Bhlhe40 (Dec1), Bhlhe41 (Dec2), ROR-α, ROR-β, 
ROR-γ, NeuroD1] are listed in Supplementary Material.
Statistical analysis
Statistical analysis of behavioral experiments was per-
formed using unpaired two-tailed Student’s t test. Compar-
isons of gene expression were based on two-way analysis 
of variance (ANOVA) (genotype × time point). Post-hoc 
pairwise comparisons with Bonferroni correction were car-
ried out where significant main effects (p < 0.05) had been 
revealed by the preceding ANOVA. In each instance, sig-
nificant outlier calculations were performed based upon the 
extreme studentized deviate methods using the Grubbs’ test. 
All data were analyzed using SPSS (IBM, SPSS 18.0) statis-
tical software with the alpha level set at 0.05 at all instances.
Results
Behavioral analysis of Cry2+/+ and Cry2−/−
Cry2−/− mice exhibit lower sucrose preference
For the assessment of anhedonic behavior, one of the two 
core symptoms of depression in humans (DSM-V; Ameri-
can Psychiatric Association 2013), Cry2−/− mice and wild-
type littermates Cry2+/+ were subjected to the SPT. A sig-
nificant reduction in the preference for sucrose was found 
in Cry2−/− mice; t(20) = 3.80, P < 0.01 (Fig. 1a). No sig-
nificant differences in body weight were detected between 
groups [Cry2+/+ 25.0 ± 0.3 g, Cry2−/− 24.1 ± 0.6 g; 
t(22) = 1.33, P > 0.05].
Cry2−/− mice exhibit reduced latency to first feeding event
In order to evaluate depression-related hyponeophagia 
in Cry2−/− mice, the NSF (Fig. 1b), a standardized test 
responsive to chronic, but not acute antidepressant treat-
ment (Bodnoff et al. 1989; Dulawa et al. 2004; Merali 
et al. 2003), was employed. Reduced hyponeophagia, as 
reflected in a significant decrease in the time to initiate 
feeding, was observed in Cry2−/− compared to Cry2+/+ 
animals [t(21) = 0.51, P < 0.05]. No significant differ-
ences in home-cage food consumption were detected 
[t(21) = 2.19, P > 0.05) (Fig. 1c).
Cry2−/− mice demonstrate unaltered behavior in the forced 
swim test and in the tail suspension test
Cry2+/+ and Cry2−/− mice were tested in two standardized 
paradigms for the assessment of depression-related behav-
ioral despair in rodents, the FST (Fig. 1d) and the TST 
(Fig. 1e). In both tests, the time spent immobile is used as a 
parameter indicative of depression-like behavior. No differ-
ences between Cry2+/+ and Cry2−/− mice were observed in 
either test.
To control for alterations in locomotor activity or motor 
coordination potentially confounding the performance in 
the FST and TST, OF (Fig. 2a, b) analysis and Rota Rod 
(Fig. 2c) analysis were carried out. No differences between 
Cry2−/− and Cry2+/+ mice were observed in any of the 
parameters evaluated.
Cry2−/− mice showed unaltered anxiety‑like behavior
To investigate whether the deficiency in Cry2 modulated 
anxiety-like behavior, Cry2−/− and Cry2+/+ mice were 
subjected to the EPM and the LD tests. No differences in 
anxiety-like behavior, as represented by percentage of time 
spent in open arms and the percentage of open arms entries 
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in the EPM test (Fig. 2d, e), and time spent and entries into 
the light zone in the LD test (Fig. 2f, g) were observed 
between genotypes.
Diurnal amygdala gene expression profile
Aiming to explore the molecular correlates of the observed 
behavioral phenotype of Cry2−/− mice, we focused on gene 
expression analysis in the basolateral amygdala, critically 
involved in the regulation of emotional states and related to 
the pathophysiology of mood disorders (Ressler and May-
berg 2007). Diurnal profiles of clock genes—alterations 
of which have been previously reported in both depressed 
patients and animal models of the disease (Li et al. 2013; 
Savalli et al. 2014)—and neurotrophic and growth factors 
implicated in the neurobiological alterations of depression 
were analyzed in Cry2−/− and Cry2+/+ mice by qRT-PCR. 
Mice of both genotypes were randomly divided into two 
groups and basolateral amygdala samples were collected 
at two different time points, ZT 0.5 (light) and ZT 12.5 
(dark). 20 core clock genes were examined, all of which 
were found to be expressed in the analyzed samples (Sup-
plementary Table 1a). Two-way ANOVA analysis revealed 
a statistically significant interaction between genotype and 
time point [F(1,19) = 5.89; P < 0.05] for basic helix-loop-
helix family, member e40 (Bhlhe40) also known as deleted 
in esophageal cancer 1 (Dec1) (Fig. 3a), without signifi-
cant main effect. For D site of albumin promoter (albumin 
D-box) binding protein (Dbp), a significant main effect 
of time point [F(1,19) = 9.44; P < 0.01; Fig. 3b], without 
effect of genotype [F(1,19) = 0.58; P > 0.05] or interaction 
between genotype and time point [F(1,19) = 2.09; P > 0.05], 
was detected. For nuclear receptor subfamily 1, group 
D, member 2 (Nr1d2) also known as Rev-erbβ, a signifi-
cant main effect of time point [F(1,19) = 21.99; P < 0.001; 
Fig. 3c] was observed, but no significant main effect of 
genotype [F(1,19) = 0.24; P > 0.05] or interaction between 
genotype and time point [F(1,19) = 2.38; P > 0.05] was 
Fig. 1  Effect of disruption of the Cry2 gene on anhedonia, hypone-
ophagia and behavioral despair. In comparison to wild-type litter-
mates (Cry2+/+), Cry2−/− mice displayed a lower sucrose preference 
in the sucrose preference test (SPT) (n = 11 per genotype). In the 
novelty suppressed feeding (NSF) test Cry2−/− mice showed b lower 
latency to food consumption in a novel environment and c unal-
tered food consumption in the home cage (Cry+/+ n = 11; Cry2−/− 
n = 12). Behavioral despair evaluated in d the forced swim test 
(FST) (n = 12 per genotype) and e tail suspension test (TST) (Cry+/+ 
n = 12; Cry2−/− n = 11) was comparable between genotypes. Data 
are displayed as mean ± SEM. *P < 0.05; **P < 0.01
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revealed. No statistically significant differences for the 
other clock genes analyzed were observed (Supplementary 
Table 1b).
qRT-PCR analysis of mRNA levels of molecular ele-
ments of growth factor systems highly implicated in 
the pathophysiology of depression (Yu and Chen 2011; 
Fig. 2  Effect of disruption of the Cry2 gene on locomotion, motor 
coordination and anxiety-like behavior. Performance of Cry2−/− in 
the open field (OF)—a total distance traveled and b time spent in the 
center zone—and in the Rota Rod c (latency to fall) was compara-
ble to wild-type littermates (Cry2+/+). No differences in anxiety-like 
behavior were observed between genotypes in the elevated plus maze 
(EPM) in d percentage of time spent in open arms and e percentage 
of open arm entries, or in the light/dark box (LD) in f percentage of 
time spent in the light zone and g number of entries in the light zone. 
Data are displayed as mean ± SEM (n = 11–12 per genotype)
Fig. 3  Amygdala clock gene expression in Cry2−/− and Cry2+/+ 
mice at ZT 0.5 and ZT 12.5. Relative gene expression of the clock 
genes a Bhlhe40, b Dbp and c Nr1d2 determined by qRT-PCR in 
basolateral amygdala tissue of Cry2+/+ (white bars) and Cry2−/− 
(black bars) mice (n = 5–6 per genotype per condition). Results 
were normalized to β-actin as reference gene and plotted relative 
to the mean of the control sample at ZT 0.5. Data are displayed as 
mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001
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Clark-Raymond and Halaris 2013), namely brain-derived 
neurotrophic factor (Bdnf), vascular endothelial growth 
factor (Vegf) and their respective receptors was car-
ried out in basolateral amygdala samples of Cry2−/− and 
Cry2+/+ mice (Supplementary Table 2a). For the individ-
ual isoforms of Bdnf, two-way ANOVA revealed a signifi-
cant main effect of time point for Bdnf-I [F(1,19) = 5.61; 
P < 0.05; Fig. 4a]. No significant main effect of genotype 
[F(1,19) = 3.86; P > 0.05] or significant genotype by time 
point interaction [F(1,19) = 0.62; P > 0.05] was observed. A 
significant main effect of genotype was observed for Bdnf-
III [F(1,19) = 4.91; P < 0.05; Fig. 4b]. No significant effect 
of time point [F(1,19) = 0.35; P > 0.05] or genotype by time 
point interaction [F(1,19) = 0.91; P > 0.05] was revealed.
In the case of members of the Vegf family, there was a 
statistically significant genotype by time point interac-
tion for Vegfb [F(1,19) = 4.97; P < 0.05; Fig. 4c], without 
significant main effect of either genotype [F(1,19) = 1.02; 
P > 0.05] or time point [F(1,19) = 0.70; P > 0.05]. No sta-
tistically significant differences for the other growth factor 
genes analyzed were observed (Supplementary Table 2b).
Discussion
The present study firstly assessed the direct consequence of 
Cry2-deficiency on depression-like behavior and examined 
its molecular signature in the mouse basolateral amygdala. 
Behaviorally, increased anhedonic behavior of Cry2−/− 
mice was observed in the SPT and reduced hyponeophagia 
in the NSF test, without alterations in behavioral despair in 
the FST or TST. Anxiety-like behavior in the EPM or LD 
tests was not altered in Cry2−/− mice. Amygdala diurnal 
gene expression profiling of core clock genes and growth 
factor systems previously implicated in the pathophysi-
ology of depression revealed that levels of Bhlhe40 were 
significantly elevated in the beginning of the active (dark) 
phase in Cry2−/− mice as compared to wild-type littermates 
(Cry2+/+). Moreover, the genotype had a significant effect 
in that Bdnf-III gene expression was blunted in Cry2−/− 
mice and Vegfb levels were significantly reduced in the 
beginning of the dark phase in Cry2−/− mice.
Considering that anhedonia is one of the core symptoms 
of depression in humans and that it is commonly used as 
indicator of depression-like behavior in animal models 
(Willner et al. 1992), the observed augmented anhedonic 
behavior in Cry2−/− mice supports previous observations 
that link altered expression of Cry2 to depression, both in 
humans (Lavebratt et al. 2010) and in experimental animals 
(Griesauer et al. 2014; Savalli et al. 2014). Intact perfor-
mance of Cry2−/− mice in the FST and the TST supports 
previous findings (De Bundel et al. 2013) and suggests that 
Cry2 may be specifically relevant for the anhedonic endo-
phenotype of depression. Hence, as previously suggested 
(Lim et al. 2012), the neurobiological aberrations related 
to anhedonia differ from those mediating the display of 
despair and support the hypothesis that the diversity of 
clinical features observed in depressed patients may indeed 
be subserved by distinct underlying molecular mecha-
nisms. Interestingly, while no differences in baseline anx-
iety-like behavior were detected in the EPM, the LD and 
the OF, the significantly reduced latency to feed in Cry2−/− 
mice in the NSF is indicative of reduced hyponeophagia 
which has been associated with depression-related anxiety. 
In a different strain of Cry2−/− mice, altered performance 
in the EPM, which was not corroborated by an additional 
test assessing anxiety-like behavior, has been reported (De 
Bundel et al. 2013), and differences to our observations in 
Fig. 4  Amygdala neurotrophic factor expression in Cry2−/− mice 
and Cry2+/+ at ZT 0.5 and ZT 12.5. Relative gene expression of a 
Bdnf-I, b Bdnf-III and c Vegfb determined by qRT-PCR in basolateral 
amygdala tissue of Cry2+/+ (white bars) and Cry2−/− (black bars) 
mice (n = 5–6 per genotype per condition). Results were normal-
ized to β-actin, as reference gene and plotted relative to the mean of 
the control sample at ZT 0.5. Data are displayed as mean ± SEM. 
*P < 0.05
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three independent paradigms testing baseline anxiety-like 
behavior might relate to the specific mouse line used or 
variations in the individual experimental set-ups.
While seemingly opposing the result in the SPT, the 
intriguing observation in the NSF, however, suggests that 
Cry2 may be involved in or modulate some of the signal-
ing cascades activated by chronic antidepressant drug 
treatment which is known to induce a decreased latency to 
feed in the NSF (Dulawa et al. 2004; Mineur et al. 2009; 
Warner-Schmidt et al. 2011).
The NSF test is unique among the plethora of tests 
available to evaluate anxiety-like and depression-related 
behaviors in mice. In comparison to “classical” assays 
monitoring anxiety-like behavior, such as the EPM and 
the LD, it comprises the additional aspect of motivation, 
since through the component to food-deprivation the ani-
mal is experiencing a conflict situation in which the innate 
avoidance for open novel areas has to be reconciled with 
the incentive to consume food. On the other hand, the 
SPT also evaluates the ability to seek pleasure from the 
rewarding experience of energy consumption, which is in 
the SPT evaluated in the familiar, hence experienced as 
“safe”, home cage environment. The NSF introduces the 
elicitation of endogenous fear through the perception of 
novel, anxiogenic spaces, as added variable. This charac-
teristic set of test-specific demands may explain the dis-
tinctive position of the NSF with regard to its potential to 
selectively reveal behavioral effects of chronic antidepres-
sant treatment. Hence, considering the results of reduced 
latency to feed in the NSF, it is tempting to speculate that 
Cry2−/− mice might be more sensitive to the effects of 
antidepressant treatments, despite or even because of their 
augmented depression-related anhedonia displayed in the 
NSF. However, this interesting hypothesis warrants fur-
ther experimental evidence through the assessment of the 
behavioral and cellular effects of chronic administration 
of antidepressant drugs in a novel cohort of Cry2-deficient 
mice and wild-type littermates.
Of note, in a mouse model of an anxiety/depression-like 
state induced by chronic corticosterone treatment, chronic 
antidepressant treatment has been shown to differentially 
affect depression-like behavior in specific tests, includ-
ing the NSF, in a hippocampal neurogenesis-dependent 
manner. Hence, a particular involvement of Cry2 in the 
neurogenesis-dependent molecular pathways stimulated 
by chronic antidepressant treatment can be speculated to 
exist (David et al. 2009). Moreover, one remarkable fea-
ture of the Cry proteins is that they oppose glucocorti-
coid receptor activation and that their deficiency doubles 
the number of dexamethasone-induced genes in primary 
fibroblasts from Cry double-knockout mice (Lamia et al. 
2011). A critical balance between Cry proteins is required 
for proper clock functioning (van der Horst et al. 1999). 
Of the two Cry proteins, Cry2 has a key role in balancing 
Cry expression, since it not only acts as a general repres-
sor, but also opposes in specific actions of Cry1, denying 
Cry1 from accessing to DNA targets too early (Anand et al. 
2013). Earlier, altered regulation (down-regulation) of glu-
cocorticoid-responsive genes in the basolateral amygdala 
(Monje et al. 2011b) and selective deletion of the forebrain 
type II glucocorticoid receptor (Solomon et al. 2012) have 
been linked to increased depression-like behavior in mice. 
Cry double-knockout mice display constitutively high lev-
els of circulating corticosterone, suggesting that suppres-
sion of the hypothalamic–pituitary–adrenal axis is reduced 
and glucocorticoid transactivation in the liver is enhanced 
(Lamia et al. 2011). On the other hand, mice over-express-
ing the cerebral glucocorticoid receptor are less susceptible 
to display depression-like behavior (Schulte-Herbruggen 
et al. 2006). They have constitutively high levels of Bdnf 
protein in the hippocampus and higher levels of Bdnf pro-
tein in the amygdala, especially during the first hour of the 
passive (light) phase, when corticosteroid levels are low 
(Schulte-Herbruggen et al. 2006). In agreement, we found 
herein that Cry2-deficiency caused constitutively low levels 
of Bdnf-III mRNA in the basolateral amygdala.
It is known that Bdnf stimulates Vegfb gene expres-
sion (Takeda et al. 2005) and that Vegfb in turn stimulates 
neurogenesis in adult mice (Sun et al. 2006). It seems 
that Bhlhe40 plays a role in these cascades (Rossner et al. 
1997), but it is not known which specific Bdnf isoform is 
modulated. We here found that levels of Vegfb mRNA in 
the basolateral amygdala were reduced in the beginning of 
the active (dark) phase, suggesting a reciprocal relationship 
between Bhlhe40 and Vegfb in Cry2−/− mice. Intriguingly, 
Bhlhe40, Dbp and Nr1d2 are among the top-ranked genes 
that are rhythmically expressed in the human brain, and 
individuals with major depressive disorder appear to have 
lost the alignment between Bhlhe40 and Per2 expression 
timetables in six brain regions, e.g. in the amygdala (Li 
et al. 2013).
Another interesting feature of Cry proteins is that they 
are the actual repressors of the feedback loops in the core 
of circadian clocks (Dardente et al. 2007; Ye et al. 2011). 
In addition to their actions in the cell nucleus, Cry proteins 
act as inhibitors of adenylyl cyclase, thereby limiting cyclic 
adenosine monophosphate production (Narasimamurthy 
et al. 2012) and inhibiting the G protein coupled receptor 
activity through a direct interaction with the G(s)alpha sub-
unit (Zhang et al. 2010). By these mechanisms of action, 
as we hypothesize here, Cry proteins might protect the 
individual from a depression-like state seen in conditions 
where dysfunction in control of the mesolimbic dopamin-
ergic tracts leads to increased cyclic adenosine monophos-
phate production and increased depression-like behavior 
(Park et al. 2005).
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However, since our observations are based upon a “con-
ventional” knock-out mouse model, we cannot rule out that 
compensatory changes induced by Cry2-deficiency dur-
ing development may contribute to the observed behavio-
ral and molecular phenotype of Cry2−/− mice. Moreover, 
since Cry2-deletion in this mouse line is not restricted to 
the hippocampus, the absence of Cry2 may impact on other 
physiological activities which could in turn modulate the 
herein studied brain functions and molecular processes. 
Furthermore, since here gene expression was evaluated in 
tissue derived from animals under light-entrained circadian 
rhythms, the specific relevance of Cry2 for the behavioral 
and molecular functions evaluated under free-running con-
ditions needs to be addressed in future studies.
In conclusion, the present study provides evidence that 
deletion of Cry2 is associated with depression-like behav-
ior, namely the sucrose preference test, selectively imping-
ing on the anhedonic endophenotype of depression in the 
mouse. The distinct behavioral display was associated with 
a modulation of the diurnal pattern of expression of specific 
clock genes and growth factors in the basolateral amygdala 
of Cry2−/− mice.
On the basis of these data, we propose that Cry2 exerts 
a role in the control of emotional states by participating 
in amygdala functioning, acting on molecular elements of 
both the endogenous clock machinery and the network of 
neurotrophic support.
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